Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of human ALDH1A3 in presence of NAD+ by LC-MS/MS analysis
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
SummaryRelated BioAssays by Target
Inhibition of human ALDH1A1 in presence of NAD+ by LC-MS/MS analysis
Inhibition of full length human ALDH2 using propionaldehyde as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins in presence of NAD by luminescence microplate reader analysis
Assay data:8 Tested
Inhibition of full length human ALDH1A2 using propionaldehyde as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins in presence of NAD by luminescence microplate reader analysis
Assay data:6 Active, 5 Activity ≤ 1 µM, 8 Tested
Inhibition of full length human ALDH1A1 using propionaldehyde as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins in presence of NAD by luminescence microplate reader analysis
Inhibition of human ALDH1A3 in human WM266-4 cells incubated for 60 mins using BODIPY-aminoacetaldehyde as substrate in presence of ALDEFLUOR assay buffer by Hoechst 33342 staining based cell Insight fluorescent microscopic anlaysis
Assay data:8 Active, 8 Activity ≤ 1 µM, 8 Tested
Inhibition of full length human ALDH1A3 using propionaldehyde as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins in presence of NAD by luminescence microplate reader analysis
ALDH Assay Protocol from US Patent US11753371: "Disulfiram derivatives as ALDH1A1 and MAGL inhibitors"
Assay data:20 Active, 15 Activity ≤ 1 µM, 23 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
Inhibition of human ALDH1B1
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Inhibition of human ALDH2
Assay data:5 Active, 3 Activity ≤ 1 µM, 5 Tested
Inhibition of human ALDH1A1
Assay data:3 Active, 3 Activity ≤ 1 µM, 3 Tested
Inhibition of human ALDH1A1 assessed as fluorescent enhancement checked in presence of NAD+ by fluorescence based assay
Assay data:1 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of ALDH1A1 (unknown origin)
Assay data:6 Active, 5 Activity ≤ 1 µM, 6 Tested
Inhibition of human ALDH1A3 expressed in Escherichia coli BL21(DE3) pLys cell in presence of NAD+ by fluorescence based assay
Inhibition of human ALDH1A1 expressed in Escherichia coli BL21(DE3) pLys cell in presence of NAD+ by fluorescence based assay
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Inhibition of human ALDH1A3 using propionaldehyde substrate at 20 uM in presence of NAD+ by UV-visible spectrophometric analysis relative to control
Inhibition of human ALDH1A2 using propionaldehyde as substrate at 20 uM in presence of NAD+ by UV-visible spectrophometric analysis relative to control
Inhibition of human ALDH3A1 using propionaldehyde as substrate in presence of NAD+ by UV-visible spectrophometric analysis relative to control
Inhibition of human ALDH2 using propionaldehyde as substrate in presence of NAD+ by UV-visible spectrophometric analysis relative to control
Inhibition of recombinant human ALDH1A1 using propionaldehyde as a substrate incubated for 15 mins followed by substrate addition by fluorescence based spectrophotometric analysis
Assay data:5 Active, 5 Activity ≤ 1 µM, 5 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on